Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 6.15% | 54.02 | 0.9% | $2353.35m | |
| JNJ | Johnson & Johnson | -0.62% | 159.25 | 0.7% | $1167.23m | |
| MRK | Merck & Co., Inc. | -3.83% | 79.13 | 0.7% | $1134.44m | |
| LLY | Eli Lilly & Co. | -0.57% | 260.50 | 1.1% | $694.38m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 56.51 | 1.0% | $694.21m | |
| ABBV | AbbVie, Inc. | -1.80% | 116.53 | 1.9% | $669.66m | |
| AZN | AstraZeneca Plc | 0.43% | 56.58 | 1.0% | $278.35m | |
| GSK | GlaxoSmithKline Plc | -1.42% | 41.01 | 0.2% | $185.81m | |
| NVS | Novartis AG | -1.44% | 80.73 | 0.2% | $180.89m | |
| BFRI | Biofrontera, Inc. | 51.34% | 7.90 | 0.0% | $139.46m | |
| VTRS | Viatris, Inc. | -2.30% | 12.75 | 0.0% | $132.99m | |
| RGEN | Repligen Corp. | 5.21% | 286.01 | 6.7% | $112.80m | |
| RPRX | Royalty Pharma Plc | -0.45% | 41.89 | 0.1% | $106.76m | |
| DRNA | Dicerna Pharmaceuticals, Inc. | -0.03% | 37.99 | 0.3% | $106.72m | |
| NVO | Novo Nordisk A/S | -0.76% | 108.21 | 0.1% | $96.98m |
Company Profile
AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.